Astria Therapeutics
ATXS
ATXS
24 hedge funds and large institutions have $14.1M invested in Astria Therapeutics in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 25 → 24 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
Holders
24
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$875K | |
| 2 | +$511K | |
| 3 | +$255K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$50.5K |
| 5 |
Bank of New York Mellon
New York
|
+$25K |
Top Sellers
| 1 | -$1.35M | |
| 2 | -$489K | |
| 3 | -$183K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$94K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$29K |